4-[4-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(4-isoquinolin-4-ylphenyl)phenyl]phenyl]isoquinoline
C51H33N5 — CID 118582410
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(4-isoquinolin-4-ylphenyl)phenyl]phenyl]isoquinoline
4-[4-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(4-isoquinolin-4-ylphenyl)phenyl]phenyl]isoquinoline (PubChem CID 118582410) has the molecular formula C51H33N5 and a molecular weight of 715.86 g/mol. Its IUPAC name is 4-[4-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(4-isoquinolin-4-ylphenyl)phenyl]phenyl]isoquinoline.
Molecular Properties
| Compound Name | 4-[4-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(4-isoquinolin-4-ylphenyl)phenyl]phenyl]isoquinoline |
|---|---|
| PubChem CID | 118582410 |
| Molecular Formula | C51H33N5 |
| Molecular Weight | 715.86 g/mol |
| Exact Mass | 715.27 |
| IUPAC Name | 4-[4-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(4-isoquinolin-4-ylphenyl)phenyl]phenyl]isoquinoline |
| SMILES | c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4ccc(-c5cncc6ccccc56)cc4)cc(-c4ccc(-c5cncc6ccccc56)cc4)c3)n2)cc1 |
| InChI | InChI=1S/C51H33N5/c1-3-11-38(12-4-1)49-54-50(39-13-5-2-6-14-39)56-51(55-49)44-28-42(34-19-23-36(24-20-34)47-32-52-30-40-15-7-9-17-45(40)47)27-43(29-44)35-21-25-37(26-22-35)48-33-53-31-41-16-8-10-18-46(41)48/h1-33H |
| InChIKey | RRFVMTXLSRAJOQ-UHFFFAOYSA-N |
| XLogP | 12.64 |
| TPSA | 64.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 715.86 |
| LogP ≤ 5 | 12.64 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118582410 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.